SANTA CLARA, Calif., Nov. 16, 2017 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Alessandro Vigilante, Head of Global Innovation Ecosystem, Fidelity Investments, and Tony Mollica, Director of Innovation, Humana, have joined the roster of presenters at the 12th Annual New Product Innovation & Development : A Frost & Sullivan Executive MindXchange,
To register and download the event agenda for the 12th Annual New Product Innovation & Development: A Frost & Sullivan Executive MindXchange please visit: www.pdsxchange.com
Alessandro Vigilante will be giving the Opening Keynote, "Every Company is a Software Company: Re-imagining Your Business and its Environment in the Digital Era." His presentation will focus on how companies can keep up with the digital age. He will share process strategies and insights that participants can take back to their own organizations.
Prior to becoming the Global Head of Innovation at Fidelity, Alessandro was a Startup Mentor at Alchemist Accelerator, a young venture-backed initiative focused on accelerating the development of seed-stage ventures that monetize from enterprises. Previous to that, he was an Advocate for Corporate Venturing, FinTech, and Cyber Security at London Advocates. In his own words, Alessandro "has built a career out of building products or entire new businesses using digital technologies."
Tony Mollica will give the formal presentation "Organizational Success Story Going from Customer Focused to Customer Obsessed." Tony will share his experiences building repeatable processes that ensure the customer is at the center of every stage of the product innovation process. He will examine how organizations can avoid compromising the design principles gained through customer experience research and provide a blueprint for how to apply a model that validates whether solutions address consumer needs, are economically viable, and can be executed within the business' current capacity.
As Director of Innovation at Humana, Tony oversees the program management of a large portfolio of health improvement initiatives, including strategic partnerships, ventures, and EIR activities. Previously he was Director, Corporate Strategy and Population Health, Humana, where he designed innovative solutions to help the organization achieve its strategic goals. Specifically, he used Human-Centered Design principles to develop a series of Population Health materials and Clinical Guidelines to aid leaders in developing Community Health Profiles.
This interactive event, themed Re-imagining Business, Strategy and Innovation in the Digital Renaissance, will help executives and managers develop a roadmap for game-changing organizational transformation. Participants will acquire the strategic "big picture" understanding as well as many of the tactical tools needed to develop new products and services and drive their organizations to marketplace leadership.
For additional information, please email: firstname.lastname@example.org or call Matthew McSweegan at 516-255-3812.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
Contact:Francesca ValenteCorporate Communications AmericasP: +54 11 4777 5300F: +54 11 4777 5300E: email@example.com
View original content:http://www.prnewswire.com/news-releases/innovators-from-humana-and-fidelity-investments-to-lead-key-sessions-at-the-12th-annual-new-product-innovation--development-a-frost--sullivan-executive-mindxchange-300558038.html
SOURCE Frost & Sullivan
Subscribe to our Free Newsletters!
Bladder neck incision is a surgical procedure where cuts are made in the neck of the urinary ...
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...View All